The year-end government funding bill is currently in a precarious state, with the potential for a major health care package to be at risk if it fails to pass. This package includes a range of health care reforms that have been negotiated by both Republicans and Democrats. These reforms include changes to Pharmacy Benefit Managers (PBMs), a Medicare pay increase for doctors, an extension of telehealth services, drug patent reforms, and the initial steps towards reducing payments for hospital inpatient services.
One of the key figures in the health care industry, Elon Musk, has been making headlines recently with his involvement in PBMs. PBMs play a crucial role in the health care system by managing prescription drug benefits for insurance companies and patients. Musk’s gift to PBMs could potentially revolutionize the way these companies operate and bring about positive changes in the industry.
However, the outcome of the year-end government funding bill remains uncertain, and the fate of these health care reforms hangs in the balance. It is crucial to stay informed and keep a close eye on developments as they unfold.
For more in-depth analysis and exclusive content on this topic, consider subscribing to STAT+. By subscribing, you can gain access to premium articles, newsletters, events, and news alerts that provide valuable insights into the politics and policy of health and medicine.
To stay updated on the latest news and developments in the health care industry, sign up for D.C. Diagnosis, STAT’s twice-weekly newsletter. Receive timely updates and analysis straight to your inbox on Tuesdays and Thursdays. Stay informed and stay ahead in the ever-evolving world of health and medicine.
